<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00004728</url>
  </required_header>
  <id_info>
    <org_study_id>R01NS036643</org_study_id>
    <nct_id>NCT00004728</nct_id>
  </id_info>
  <brief_title>Aspirin Or Warfarin To Prevent Stroke</brief_title>
  <official_title>Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institute of Neurological Disorders and Stroke (NINDS)</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether aspirin or warfarin is more effective in&#xD;
      preventing stroke in patients with intracranial stenosis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prevention of stroke in patients with narrowing of one of the arteries in the brain typically&#xD;
      consists of using medications to prevent blood clots from forming. Currently, the best&#xD;
      medication to use in this situation is unknown. The purpose of this study is to compare the&#xD;
      effectiveness of two different medications, warfarin or aspirin, for the prevention of stroke&#xD;
      due to narrowing of one of the large arteries in the brain. Patients must have experienced a&#xD;
      recent transient ischemic attack (TIA) or mild stroke. Stroke of this type is thought to&#xD;
      occur more often in minorities.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <completion_date>July 2003</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <condition>Stroke</condition>
  <condition>Cerebral Infarction</condition>
  <condition>Atherosclerosis</condition>
  <condition>Constriction, Pathologic</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Warfarin</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aspirin</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  TIA or non-severe stroke within 90 days prior to randomization (including day 90)&#xD;
&#xD;
          -  Modified Rankin score of &lt; 3&#xD;
&#xD;
          -  High grade stenosis (50 to 99 percent) of a major intracranial artery (carotid artery,&#xD;
             MCA stem (M1), vertebral artery,and basilar artery) documented by conventional&#xD;
             angiography within 90 days prior to randomization (including day 90)&#xD;
&#xD;
          -  TIA or stroke is attributed to high grade intracranial stenosis&#xD;
&#xD;
          -  Age &gt; 40 years&#xD;
&#xD;
          -  Patient is able to follow an outpatient protocol(requiring monthly blood tests and&#xD;
             clinic visits every four months for the duration of the study) and is available by&#xD;
             telephone&#xD;
&#xD;
          -  Patient understands the purpose and requirements of the study, can make him/herself&#xD;
             understood, and has provided informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Extracranial carotid stenosis (&gt; 50 percent) ipsilateral to stenosis of the&#xD;
             intracranial carotid artery or MCA (ie.tandem stenoses, either of which could have&#xD;
             caused patient's symptoms)&#xD;
&#xD;
          -  Isolated stenosis of the anterior cerebral artery, posterior cerebral artery, MCA&#xD;
             division, or a distal branch of the MCA&#xD;
&#xD;
          -  Intracranial or extracranial arterial dissection, Moya Moya disease, vasculitis,&#xD;
             radiation induced vasculopathy, fibromuscular dysplasia&#xD;
&#xD;
          -  Presence of any of the following unequivocal cardiac sources of embolism: chronic or&#xD;
             paroxysmal atrial fibrillation, mitral stenosis, mechanical valve, endocarditis,&#xD;
             intracardiac clot or vegetation, myocardial infarction within three months, dilated&#xD;
             cardiomyopathy, left atrial spontaneous echo contrast&#xD;
&#xD;
          -  A contraindication to the use of either warfarin or aspirin e.g. active peptic ulcer&#xD;
             disease, active bleeding diathesis, platelets &lt; 100,000*, hematocrit &lt; 30*, clotting&#xD;
             factor abnormality that increases the risk of bleeding, alcohol or substance abuse,&#xD;
             severe gait instability, cerebral hemorrhage, systemic hemorrhage within the past&#xD;
             year, severe liver impairment (SGOT &gt; 3x normal*, cirrhosis), allergy to aspirin or&#xD;
             warfarin, uncontrolled severe hypertension (systolic pressure &gt; 180 mm Hg or diastolic&#xD;
             pressure &gt; 115mm Hg), positive stool guaiac that is not attributable to hemorrhoids,&#xD;
             creatinine &gt; 3.0*&#xD;
&#xD;
          -  Indication for intravenous heparin beyond randomization&#xD;
&#xD;
          -  A severe neurological deficit that renders the patient incapable of living&#xD;
             independently&#xD;
&#xD;
          -  Dementia or psychiatric problem that prevents the patient from following an outpatient&#xD;
             program reliably&#xD;
&#xD;
          -  Co-morbid conditions that may limit survival to less than five years&#xD;
&#xD;
          -  Pregnancy or female in age range of childbearing potential who is not using&#xD;
             contraception&#xD;
&#xD;
          -  Enrollment in another study that would conflict with the current study&#xD;
&#xD;
          -  Excluded because difficult to measure percent stenosis of these small arteries,&#xD;
             lesions are uncommon, and prognosis of patients - With these lesions is unknown * on&#xD;
             most recent test done within 90 days prior to randomization, including day 90&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc Chimowitz</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2006</verification_date>
  <study_first_submitted>February 25, 2000</study_first_submitted>
  <study_first_submitted_qc>February 25, 2000</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 28, 2000</study_first_posted>
  <last_update_submitted>June 5, 2006</last_update_submitted>
  <last_update_submitted_qc>June 5, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 6, 2006</last_update_posted>
  <keyword>stroke</keyword>
  <keyword>cerebral infarction</keyword>
  <keyword>warfarin</keyword>
  <keyword>coumadin</keyword>
  <keyword>aspirin</keyword>
  <keyword>ASA</keyword>
  <keyword>acetysalicylic acid</keyword>
  <keyword>atherosclerosis</keyword>
  <keyword>stenosis</keyword>
  <keyword>intracranial</keyword>
  <keyword>artery</keyword>
  <keyword>arteries</keyword>
  <keyword>transient ischemic attack</keyword>
  <keyword>TIA</keyword>
  <keyword>minorities</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
    <mesh_term>Warfarin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

